Reading data in migraine acute treatment studies: From clinical trials to reviews and meta-analyses

Journal of Headache and Pain

Volumn 7, Issue 3, 2006, Pages 160-164

  Buzzi, M Gabriella ^a  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Clinical trial; Meta analysis; Migraine; Triptans

Indexed keywords

ALMOTRIPTAN; FROVATRIPTAN; NARATRIPTAN; PLACEBO; RIZATRIPTAN; SUMATRIPTAN; TRIPTAN DERIVATIVE;

ANALGESIA; CLINICAL PROTOCOL; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; METHODOLOGY; MIGRAINE; NAUSEA; PAIN ASSESSMENT; PHONOPHOBIA; PHOTOPHOBIA; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZATION; REVIEW; STATISTICAL ANALYSIS; SYMPTOM; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VOMITING; ACUTE DISEASE; INFORMATION DISSEMINATION; LITERATURE;

ACUTE DISEASE; CLINICAL TRIALS; HUMANS; INFORMATION DISSEMINATION; META-ANALYSIS; MIGRAINE DISORDERS; RESEARCH DESIGN; REVIEW LITERATURE;

EID: 33746863349     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-006-0295-1     Document Type: Review

References (16)

1. Sackett DL, Richardson WS, Rosenberg WM, Haynes BR (1999) Evidence-based medicine. How to practice and teach EBM. Churchill Livingstone, New York
2. Sheftell FD, Tepper SJ (2002) New paradigms in the recognition and acute treatment of migraine. Headache 42:58-69
3. Headache Classification Committee of the International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8[Suppl 7]:1-96
4. Pilgrim AJ (1991) Methodology of clinical trials of sumatriptan in migraine and cluster headache. Eur Neurol 31:295-299
5. International Headache Society Clinical Trial Subcommittee (2000) Guidelines for controlled trials of drugs in migraine, second edition. Cephalalgia 20:765-786
6. Mathew NT, Kailasam J, Meadors L (2004) Early treatment of migraine with rizatriptan: A placebo-controlled study. Headache 44:673-699
7. Dodick DW (2003) A review of the clinical efficacy and tolerability of almotriptan in acute migraine. Expert Opin Pharmacother 4:1157-1163
8. Ryan R, Geraud G, Goldstein J, Cady R, Keywood C (2002) Clinical efficacy of frovatriptan: Placebo-controlled study. Headache 42[Suppl 2]:S84-S92
9. Geraud G, Spierings ELH, Keywood C (2002) Tolerability and safety of frovatriptan with short-and long-term use for treatment of migraine and in comparison with sumatriptan. Headache 42[Suppl 2]:S93-S99
10. Tfelt-Hansen P, Steiner T (2003) The truth about frovatriptan. Headache 43:699-700
11. Lipton RB, Pascual J, Goadsby PJ, Massiou H, McCarroll KA, Vandormael K, Jiang K, Lines CR (2001) Effect of rizatriptan and other triptans on the nausea symptom of migraine: A post hoc analysis. Headache 41:754-763
12. Ferrari MD, Roon KI, Lipton RB, Goadsby PJ (2001) Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: A meta-analysis of 53 trials. Lancet 358:1668-1675
13. Buzzi MG, Fabbri L (2000) New methods for evaluating acute treatments in migraine. Funct Neurol 15[Suppl 3]:192-195
14. Belsey J (2001) Reconciling effectiveness and tolerability in oral triptan therapy: A quantitative approach to decision making in migraine management. J Clin Res 4:105-125
15. Lanteri-Minet M (2005) What do patients want from their acute migraine therapy? Eur Neurol 53[Suppl 1]:3-9
16. Tfelt-Hansen P (2006) Understanding clinical trials in migraine. J Headache Pain 7:101-108